article thumbnail

OIG audit: Aetna may have raked in $25.5M in MA overpayments in 2015, 2016

Fierce Healthcare

million in overpayments from Medicare Advantage in 2015 and 2016. | million in overpayments from Medicare Advantage in 2015 and 2016. A new federal audit estimates that Aetna may have received at least $25.5 A new federal audit estimates that Aetna may have received at least $25.5

94
article thumbnail

Biosimilars: Are They Delivering the Cost Savings Promised?

Pharmacy Times

Since the first FDA biosimilar approval of filgrastim-sndz (Zarxio) in 2015, a total of 44 biosimilars for 15 originator products have been approved and more than 20 are marketed.

FDA 152
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

3rd time's the charm: AbbVie scores FDA nod for continuous Parkinson's disease therapy Vyalev

Fierce Pharma

AbbVie made history in 2015 with its Parkinson’s disease infusion pump therapy Duopa, kicking off a trend of delivery system innovation in the space as drugmakers sought to avoid the common pitfall | The 24-hour Parkinson's disease therapy crossed the FDA finish line after an initial manufacturing-related rejection last year and another snub in (..)

FDA 126
article thumbnail

With placenta-on-a-chip, researchers hope to gauge how drugs and toxins impact pregnancy

STAT

Early in her pregnancy in 2015, Nicole Hashemi wanted to know how much caffeine was safe for her to consume. “I was actually advised not to drink a lot of caffeine,” Hashemi, an associate professor of mechanical engineering at Iowa State University, told STAT.

130
130
article thumbnail

Precision medicine company Tempus AI files to go public

Fierce Healthcare

Founded in 2015, Tempus says it’s built the world’s largest library of clinical and molecular data along with an operating system to make those data accessible and useful for providers to inform patient care. Three years after talks of an IPO surfaced, health tech company Tempus AI lit the fuse and is looking to go public this year.

article thumbnail

Mallinckrodt sells Therakos unit on at a discount

pharmaphorum

Mallinckrodt agrees to sell Therakos to private equity firm CVC $925m, well below the $1.33bn it paid for the business in 2015

105
105
article thumbnail

Zuckerberg and Chan announce a New York biohub to build disease-fighting cellular machines

STAT

The new initiative, publicly revealed at the 2023 STAT Summit and previewed exclusively to STAT, is the latest program from the Chan Zuckerberg Initiative, or CZI, a company the couple founded in 2015 to help cure, prevent, or manage all disease by 2100. Read the rest…

142
142